PGILX
Price
$38.01
Change
+$0.13 (+0.34%)
Updated
Jul 25 closing price
Net Assets
693.72M
RGEBX
Price
$80.73
Change
+$0.27 (+0.34%)
Updated
Jul 25 closing price
Net Assets
328.1B
Interact to see
Advertisement

PGILX vs RGEBX

Header iconPGILX vs RGEBX Comparison
Open Charts PGILX vs RGEBXBanner chart's image
Putnam Focused Equity Y
Price$38.01
Change+$0.13 (+0.34%)
VolumeN/A
Net Assets693.72M
American Funds Growth Fund of Amer R2E
Price$80.73
Change+$0.27 (+0.34%)
VolumeN/A
Net Assets328.1B
PGILX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGILX vs. RGEBX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGILX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. PGILX (694M). PGILX pays higher dividends than RGEBX: PGILX (0.30) vs RGEBX (0.00). PGILX was incepted earlier than RGEBX: PGILX (17 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than PGILX (0.86). PGILX is a more actively managed with annual turnover of: 30.00 vs. RGEBX (25.00). PGILX has a lower initial minimum investment than RGEBX: PGILX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 16.90 vs. PGILX (10.10). PGILX return over 5 years is better than : 71.76 vs. RGEBX (45.14).
PGILXRGEBXPGILX / RGEBX
Total Expense Ratio0.861.0979%
Annual Report Gross Expense Ratio0.861.0979%
Fund Existence17 years11 years-
Gain YTD9.00513.00469%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets694M328B0%
Annual Yield % from dividends0.300.00-
Returns for 1 year10.1016.9060%
Returns for 3 years50.3955.9590%
Returns for 5 years71.7645.14159%
Returns for 10 years137.9478.81175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMRT1.140.05
+4.59%
SmartRent
KTTA0.74N/A
N/A
Pasithea Therapeutics Corp
CMPR48.46-0.01
-0.02%
Cimpress plc
MORN278.03-0.32
-0.11%
Morningstar
RSSS2.76-0.02
-0.72%
Research Solutions